China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review

Date: June 1, 2016
Pages: 51
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C14F0B168DBEN
Leaflet:

Download PDF Leaflet

China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review
China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

China Pharma Holdings, Inc. (China Pharma) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded pharmaceutical products. The company provides western and traditional Chinese medicines in the areas of central nervous system, cardiovascular, cerebrovascular, wound recovery, digestive disease, and infectious diseases. China Pharma offers products in the various dosage forms including lyophilized injectables, capsules, tablets, granules, injectables, and oral fluids. The company markets its products in various provinces through a network of sales offices across China. The company operates through its wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. China Pharma is headquartered in Haikou, Hainan, China.

China Pharma Holdings, Inc. Key Recent Developments

May 17, 2016: China Pharma Holdings Reports First Quarter Financial Results
Mar 31, 2016: China Pharma Holdings Reports Full Year 2015 Financial Results
Nov 17, 2015: China Pharma Holdings Reports Third Quarter 2015 Financial Results
Aug 14, 2015: China Pharma Holdings Reports Second Quarter 2015 Financial Results
Jul 31, 2015: CPHI Received CNY 9.6 Million In Government Subsidies

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

China Pharma Holdings, Inc. - Key Facts
China Pharma Holdings, Inc. - Key Employees
China Pharma Holdings, Inc. - Key Employee Biographies
China Pharma Holdings, Inc. - Major Products and Services
China Pharma Holdings, Inc. - Pharmaceutical Pipeline Products Data
China Pharma Holdings, Inc., Pipeline Products by Therapy Area
China Pharma Holdings, Inc., Pipeline Products by Development Phase
China Pharma Holdings, Inc. - History
China Pharma Holdings, Inc. - Company Statement
China Pharma Holdings, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

China Pharma Holdings, Inc. - Business Description
China Pharma Holdings, Inc. - Corporate Strategy
China Pharma Holdings, Inc. - SWOT Analysis
SWOT Analysis - Overview
China Pharma Holdings, Inc. - Strengths
Strength - Operational Network
Strength - Niche Product Offerings
Strength - Focused Research and Development Activities
China Pharma Holdings, Inc. - Weaknesses
Weakness - Higher Cost Structure
Weakness - Working Capital Concerns
China Pharma Holdings, Inc. - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Promising Product Pipeline
Opportunity - Rising Healthcare Expenditure
China Pharma Holdings, Inc. - Threats
Threat - Uncertain R&D Outcomes
Threat - Intense Competition
Threat - Pricing Control in China
China Pharma Holdings, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 17, 2016: China Pharma Holdings Reports First Quarter Financial Results
Mar 31, 2016: China Pharma Holdings Reports Full Year 2015 Financial Results
Nov 17, 2015: China Pharma Holdings Reports Third Quarter 2015 Financial Results
Aug 14, 2015: China Pharma Holdings Reports Second Quarter 2015 Financial Results
Jul 31, 2015: CPHI Received CNY 9.6 Million In Government Subsidies
May 12, 2015: China Pharma Holdings Reports First Quarter 2015 Financial Results
Mar 31, 2015: China Pharma Holdings Reports Full Year 2014 Financial Results

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

China Pharma Holdings, Inc., Key Facts
China Pharma Holdings, Inc., Key Employees
China Pharma Holdings, Inc., Key Employee Biographies
China Pharma Holdings, Inc., Major Products and Services
China Pharma Holdings, Inc., Number of Pipeline Products by Therapy Area
China Pharma Holdings, Inc., Number of Pipeline Products by Development Stage
China Pharma Holdings, Inc., Pipeline Products By Therapy Area and Development Phase
China Pharma Holdings, Inc., History
China Pharma Holdings, Inc., Subsidiaries
China Pharma Holdings, Inc., Key Competitors
China Pharma Holdings, Inc., Ratios based on current share price
China Pharma Holdings, Inc., Annual Ratios
China Pharma Holdings, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

China Pharma Holdings, Inc., Pipeline Products by Therapy Area
China Pharma Holdings, Inc., Pipeline Products by Development Phase
China Pharma Holdings, Inc., Performance Chart (2011 - 2015)
China Pharma Holdings, Inc., Ratio Charts

COMPANIES MENTIONED

Otsuka Holdings Co., Ltd.
China Nuokang Bio-Pharmaceutical Inc.
Henan Topfond Pharmaceutical Co., Ltd.
Skip to top


Ask Your Question

China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: